Cloudbreak posts ph. 3 eye disease win amid IPO storm
Cloudbreak posts ph. 3 eye disease win amid IPO storm
Cloudbreak Pharma
Private
Clinical-stage ophthalmology company developing first-in-class drugs for chronic eye diseases, including CBT-001 for pterygium and CBT-004 for vascularised pinguecula.
Company Info
Sector:Biotechnology
Headquarters:Irvine, California, United States
Founded:2015
Website:cloudbreakpharma.com/